Lv11
52 积分 2024-04-29 加入
Beyond CRBN and VHL: DCAF16-Recruiting Degraders from Rational Design to Clinical Translation
4天前
已完结
A bivalent molecular glue linking lysine acetyltransferases to oncogene-induced cell death
4天前
已完结
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
15天前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
15天前
已完结
From Ubiquitination to Proteasome-Directed Recruiting: Emerging Mechanisms and Therapeutic Potential in Targeted Protein Degradation
18天前
已完结
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies
26天前
已完结
Recent advances in the discovery of ALKBH 1–8 inhibitors
29天前
已完结
Using Data Science To Guide Aryl Bromide Substrate Scope Analysis in a Ni/Photoredox-Catalyzed Cross-Coupling with Acetals as Alcohol-Derived Radical Sources
1个月前
已完结
Diversified design strategies for small-molecule PROTACs: How do we select?
1个月前
已完结
Recent advances in developing targeted protein degraders
1个月前
已完结
皖公网安备34019202002308
